{"target_list": {"台灣艾威群股份有限公司": {"source_list": [{"holder": "1", "name": "美時化學製藥股份有限公司"}], "taxcode": "53339500"}, "美喬生技有限公司": {"source_list": [{"holder": "1", "name": "美時化學製藥股份有限公司"}], "taxcode": "54181719"}, "Lotus Pharmaceutical, HK Inc.": {"source_list": [{"holder": "1", "name": "美時化學製藥股份有限公司"}], "taxcode": "NA"}, "Alvogen Korea Holdings Ltd.": {"source_list": [{"holder": "1", "name": "美時化學製藥股份有限公司"}], "taxcode": "NA"}, "Alvogen Korea Co., Ltd.": {"source_list": [{"holder": "0.82", "name": "Alvogen Korea Holdings Ltd."}], "taxcode": "NA"}, "Dream Pharmaceutical Co., Ltd.": {"source_list": [{"holder": "0", "name": "Alvogen Korea Co., Ltd."}], "taxcode": "NA"}, "Lotus Lab, Ltd.": {"source_list": [{"holder": "1", "name": "美時化學製藥股份有限公司"}], "taxcode": "NA"}, "Lotus International Pte. Ltd.": {"source_list": [{"holder": "1", "name": "美時化學製藥股份有限公司"}], "taxcode": "NA"}, "Norwich Clinical Services Private Limited": {"source_list": [{"holder": "1", "name": "Alvogen Pharma India Pvt Ltd."}], "taxcode": "NA"}, "樂特仕生物科技諮詢(上海)有限公司": {"source_list": [{"holder": "1", "name": "Lotus International Pte. Ltd."}], "taxcode": "NA"}, "美時化學製藥股份有限公司": {"source_list": [{"holder": "NA", "name": "香港商ALVOGEN ASIA PACIFIC HOLDINGS LIMITED"}], "taxcode": "11456110"}, "Alvogen Pharma India Pvt Ltd.": {"source_list": [{"holder": "0.98", "name": "美時化學製藥股份有限公司"}], "taxcode": "NA"}, "恆康生技醫藥股份有限公司": {"source_list": [{"holder": "0.3369", "name": "美時化學製藥股份有限公司"}], "taxcode": "27354666"}}, "company_list": [{"taxcode_source": "NA", "target": "Alvogen Korea Co., Ltd.", "has_fine": false, "source": "Alvogen Korea Holdings Ltd.", "holder": "0.82", "taxcode_target": "NA"}, {"taxcode_source": "11456110", "target": "Alvogen Korea Holdings Ltd.", "has_fine": false, "source": "美時化學製藥股份有限公司", "holder": "1", "taxcode_target": "NA"}, {"taxcode_source": "11456110", "target": "Alvogen Pharma India Pvt Ltd.", "has_fine": false, "source": "美時化學製藥股份有限公司", "holder": "0.98", "taxcode_target": "NA"}, {"taxcode_source": "NA", "target": "Dream Pharmaceutical Co., Ltd.", "has_fine": false, "source": "Alvogen Korea Co., Ltd.", "holder": "0", "taxcode_target": "NA"}, {"taxcode_source": "11456110", "target": "Lotus International Pte. Ltd.", "has_fine": false, "source": "美時化學製藥股份有限公司", "holder": "1", "taxcode_target": "NA"}, {"taxcode_source": "11456110", "target": "Lotus Lab, Ltd.", "has_fine": false, "source": "美時化學製藥股份有限公司", "holder": "1", "taxcode_target": "NA"}, {"taxcode_source": "11456110", "target": "Lotus Pharmaceutical, HK Inc.", "has_fine": false, "source": "美時化學製藥股份有限公司", "holder": "1", "taxcode_target": "NA"}, {"taxcode_source": "NA", "target": "Norwich Clinical Services Private Limited", "has_fine": false, "source": "Alvogen Pharma India Pvt Ltd.", "holder": "1", "taxcode_target": "NA"}, {"taxcode_source": "11456110", "target": "台灣艾威群股份有限公司", "has_fine": false, "source": "美時化學製藥股份有限公司", "holder": "1", "taxcode_target": "53339500"}, {"taxcode_source": "11456110", "target": "恆康生技醫藥股份有限公司", "has_fine": false, "source": "美時化學製藥股份有限公司", "holder": "0.3369", "taxcode_target": "27354666"}, {"taxcode_source": "NA", "target": "美時化學製藥股份有限公司", "has_fine": false, "source": "香港商ALVOGEN ASIA PACIFIC HOLDINGS LIMITED", "holder": "NA", "taxcode_target": "11456110"}, {"taxcode_source": "11456110", "target": "美喬生技有限公司", "has_fine": false, "source": "美時化學製藥股份有限公司", "holder": "1", "taxcode_target": "54181719"}, {"taxcode_source": "NA", "target": "樂特仕生物科技諮詢(上海)有限公司", "has_fine": false, "source": "Lotus International Pte. Ltd.", "holder": "1", "taxcode_target": "NA"}], "company_summery": {"has_fine": false, "fine_penalty_amount": 0, "company_amount": 14, "group_name": "美時製藥", "fine_record_num": 0, "group_no": "G1795", "fine_company_amount": 0}, "fine_company_list": []}